Literature DB >> 18772103

Adherence, anti-adherence, and oligosaccharides preventing pathogens from sticking to the host.

Kari D Shoaf-Sweeney1, Robert W Hutkins.   

Abstract

For many pathogenic bacteria, infections are initiated only after the organism has first adhered to the host cell surface. If adherence can be inhibited, then the subsequent infection can also be inhibited. This approach forms the basis of anti-adherence strategies, which have been devised to prevent a variety of bacterial infections. In this chapter, the molecular basis by which respiratory, urinary, and gastrointestinal tract pathogens adhere to host cells will be described. The five general types of anti-adherence agents will also be reviewed. The most well-studied are the receptor analogs, which include oligosaccharides produced synthetically or derived from natural sources, including milk, berries, and other plants. Their ability to inhibit pathogen adherence may lead to development of novel, food-grade anti-infective agents that are inexpensive and safe.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18772103     DOI: 10.1016/S1043-4526(08)00402-6

Source DB:  PubMed          Journal:  Adv Food Nutr Res        ISSN: 1043-4526


  23 in total

1.  Effect of different feed ingredients and additives on IPEC-J2 cells challenged with an enterotoxigenic Escherichia coli strain.

Authors:  F Spitzer; S Speiser; W Vahjen; J Zentek
Journal:  Cytotechnology       Date:  2015-08-15       Impact factor: 2.058

2.  Sequential One-Pot Multienzyme Chemoenzymatic Synthesis of Glycosphingolipid Glycans.

Authors:  Hai Yu; Yanhong Li; Jie Zeng; Vireak Thon; Dung M Nguyen; Thao Ly; Hui Yu Kuang; Alice Ngo; Xi Chen
Journal:  J Org Chem       Date:  2016-10-24       Impact factor: 4.354

Review 3.  Pathogen-induced secretory diarrhea and its prevention.

Authors:  S Anand; S Mandal; P Patil; S K Tomar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-29       Impact factor: 3.267

4.  Galactooligosaccharide supplementation provides protection against Citrobacter rodentium-induced colitis without limiting pathogen burden.

Authors:  Hatem Kittana; Maria I Quintero-Villegas; Laure B Bindels; João Carlos Gomes-Neto; Robert J Schmaltz; Rafael R Segura Munoz; Liz A Cody; Rodney A Moxley; Jesse Hostetter; Robert W Hutkins; Amanda E Ramer-Tait
Journal:  Microbiology       Date:  2017-12-19       Impact factor: 2.777

5.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by lactoferrin.

Authors:  Maria I Quintero-Villegas; Anja Wittke; Robert Hutkins
Journal:  Curr Microbiol       Date:  2014-06-14       Impact factor: 2.188

6.  Adherence inhibition of Cronobacter sakazakii to intestinal epithelial cells by prebiotic oligosaccharides.

Authors:  Maria Quintero; Maria Maldonado; Mariaelisa Perez-Munoz; Roberto Jimenez; Terry Fangman; John Rupnow; Anja Wittke; Michael Russell; Robert Hutkins
Journal:  Curr Microbiol       Date:  2011-02-04       Impact factor: 2.188

7.  Human isolates of Cronobacter sakazakii bind efficiently to intestinal epithelial cells in vitro to induce monolayer permeability and apoptosis.

Authors:  Quin Liu; Rahul Mittal; Claudia N Emami; Carol Iversen; Henri R Ford; Nemani V Prasadarao
Journal:  J Surg Res       Date:  2011-11-15       Impact factor: 2.192

8.  Exopolysaccharides synthesized by Lactobacillus reuteri protect against enterotoxigenic Escherichia coli in piglets.

Authors:  Xiao Yan Chen; Adrienne Woodward; Ruurd T Zijlstra; Michael G Gänzle
Journal:  Appl Environ Microbiol       Date:  2014-07-11       Impact factor: 4.792

Review 9.  Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods.

Authors:  Delphine M A Saulnier; Jennifer K Spinler; Glenn R Gibson; James Versalovic
Journal:  Curr Opin Biotechnol       Date:  2009-02-24       Impact factor: 9.740

10.  The role of milk sialyllactose in intestinal bacterial colonization.

Authors:  G Adrienne Weiss; Thierry Hennet
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.